Latest News for: hifu

Edit

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement ...

Nasdaq Globe Newswire 16 Jun 2026
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical ... .
Edit

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer

The Eagle-Tribune 16 Jun 2026
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical ... .
Edit

Sonire Therapeutics Completes Enrollment in SUNRISE-I Randomized Controlled Trial of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

PR Newswire 01 Jun 2026
Pivotal Japan-based study evaluates efficacy and safety of non-invasive HIFU system in pancreatic cancer, complementing ongoing U.S ... HIFU therapy represents an innovative approach that is distinct from existing treatments.
Edit

EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in

Hastings Tribune 14 May 2026
, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq. EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) to explore joint clinical research ... .
Edit

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

Nasdaq Globe Newswire 07 May 2026
, May 07, 2026 (GLOBE NEWSWIRE) --. EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue ... .
Edit

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue (Form 8-K) (Edap TMS SA)

Public Technologies 07 May 2026
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue. Seventh Consecutive Quarter of Year-Over-Year HIFU Revenue Growth · 78% Growth in First Quarter HIFU Revenue Year-Over-Year ... HIFU Procedures Year-Over-Year.
Edit

Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

Albany Democrat Herald 02 May 2026
SUNRISE-II feasibility trial marks the company's entry into U.S. clinical development, advancing ....
Edit

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One� Robotic HIFU in ...

Nasdaq Globe Newswire 30 Apr 2026
, April 30, 2026 (GLOBE NEWSWIRE) --. EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One� Robotic HIFU in Radiorecurrent Prostate Cancer ... .
Edit

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer (Edap TMS SA)

Public Technologies 30 Apr 2026
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer ... Today, the NCCN guidelines recommend HIFU as a treatment option for patients with recurrence in the prostate.
Edit

Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development

PR Newswire 15 Apr 2026
Led by Santé, the funding will support completion of the world's first randomized HIFU trial for pancreatic cancer, and accelerate U.S ... Sonire's proprietary High-Intensity Focused Ultrasound (HIFU) ...
Edit

Why Is HIFU Skin Tightening Effective?

GetNews 01 Apr 2026
Among the many technologies available today, HIFU (High-Intensity Focused Ultrasound) has gained significant attention for its ability to lift and tighten skin without surgery ... What Is HIFU Skin Tightening? ... How Does a HIFU Machine Work?.
Edit

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

Enid News & Eagle 25 Mar 2026
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue ... .
Edit

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue (Form 8-K) (Edap TMS SA)

Public Technologies 25 Mar 2026
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue • 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of U.S.
  • 1

Article Search

tools
×
×
×
×